Adjunctive perampanel in partial‐onset seizures: Asia‐Pacific, randomized phase III study
Sign Up to like & getrecommendations! Published in 2018 at "Acta Neurologica Scandinavica"
DOI: 10.1111/ane.12883
Abstract: To evaluate the efficacy, safety, and tolerability of perampanel, a selective, non‐competitive, α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptor antagonist, as an adjunctive treatment for patients with refractory partial‐onset seizures (POS) from Asia‐Pacific. read more here.
Keywords: asia pacific; adjunctive perampanel; partial onset; onset seizures ... See more keywords
Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to
Sign Up to like & getrecommendations! Published in 2020 at "Epilepsia"
DOI: 10.1111/epi.16413
Abstract: Study 311 (NCT02849626) was a global, multicenter, open‐label, single‐arm study that assessed safety, tolerability, pharmacokinetics, and pharmacokinetics/pharmacodynamics of once‐daily adjunctive perampanel oral suspension in pediatric patients (aged 4 to read more here.
Keywords: adjunctive perampanel; tonic clonic; study; clonic seizures ... See more keywords